# Seaport Therapeutics, Inc.: Form SCHEDULE 13D, filed May 6, 2026

- Company: [Seaport Therapeutics, Inc.](/companies/sptx.md) (CIK 2042347)
- Form: SCHEDULE 13D
- Filed: 2026-05-06
- Accepted by EDGAR: May 6, 2026, 16:26 ET
- Period: not reported
- Accession: 0001193125-26-209100
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/2042347/000119312526209100/xslSCHEDULE_13D_X02/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/2042347/000119312526209100/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/2042347/000119312526209100/xslSCHEDULE_13D_X02/primary_doc.xml

Filed May 6, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-209100. Last ingested by Listed: Nov 14, 2026, 11:27 ET. No prices; not investment advice.
